stockrowAccuray Incorporated
ARAY Healthcare Medical Devices
Accuray Incorporated’s revenue for fiscal 2026 (year ended June 2026) was $401.9 million, down 12.3% from fiscal 2025.
- Revenue
- −7.90%
- EPS
- +138.9%
- Free cash flow
- −138.3%
- Total debt
- −25.4%
Quarter to September 2026, against a year earlier
Follow ARAY
Alert me
Accuray Incorporated (ARAY) EV/Sales
As of 6 November 2026, Accuray Incorporated (ARAY) trades at a EV/Sales of 0.2×. Over the past ten years it has ranged from 0.2× (November 2026) to 2.2× (April 2015) — the current reading is the lowest in ten years. That is below the Medical Devices industry median of 2.8× and below the Healthcare sector median of 3.6×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2026 | 0.3× | (24.35%) |
| FY2025 | 0.5× | (25.00%) |
| FY2024 | 0.6× | (40.09%) |
| FY2023 | 1.0× | 63.62% |
| FY2022 | 0.6× | (48.22%) |
| FY2021 | 1.2× | 72.21% |
| FY2020 | 0.7× | (30.61%) |
| FY2019 | 1.0× | 4.30% |
| FY2018 | 0.9× | 8.84% |
| FY2017 | 0.9× | (17.23%) |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Sep 2026 | 0.2× | (32.30%) |
| Jun 2026 | 0.3× | 1.49% |
| Mar 2026 | 0.3× | (19.39%) |
| Dec 2025 | 0.4× | (28.29%) |
| 43 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| ITOC iTonic Holdings Ltd. compare | n/m |
| RBOT Vicarious Surgical Inc. compare | n/m |
| ARAY Accuray Incorporated | 0.2× |
| CTSO Cytosorbents Corporation compare | 0.7× |
| LFWD Lifeward Ltd. compare | 0.8× |
| ALUR Allurion Technologies, Inc. compare | 5.3× |
| PETV PetVivo Holdings, Inc. compare | 19.7× |
| PAVM PAVmed Inc. compare | 189× |
| HSCS HeartSciences Inc. compare | 519× |
| Medical Devices industry median | 2.8× |
| Healthcare sector median | 3.6× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)